SYRE vs GOOGL: Which Stock is Better?

Side-by-side comparison of Spyre Therapeutics Inc and Alphabet Inc in 2026

Comparison Updated:

SYRE

Spyre Therapeutics Inc

$73.01

GOOGL

Alphabet Inc

$338.20

Key Metrics Comparison

MetricSYREGOOGLWinner
Market Cap$5.94BN/ASYRE
P/E RatioN/A31.64GOOGL
EPS (TTM)$N/A$10.80GOOGL
Revenue Growth0.0%0.2%GOOGL
Gross Margin0.0%59.7%GOOGL

Analyze SYRE

Full quant analysis

Analyze GOOGL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SYRE or GOOGL a better investment?

Comparing SYRE and GOOGL: Spyre Therapeutics Inc has a market cap of $5.94B while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SYRE and GOOGL?

SYRE (Spyre Therapeutics Inc) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SYRE or GOOGL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: SYRE or GOOGL?

GOOGL has higher revenue growth at 0.2% vs 0.0% for SYRE.

Which company is more profitable: SYRE or GOOGL?

Alphabet Inc (GOOGL) has higher gross margins at 59.7% compared to 0.0% for SYRE.

Which is the larger company: SYRE or GOOGL?

Spyre Therapeutics Inc (SYRE) is larger with a market cap of $5.94B compared to N/A for GOOGL.

Should I buy SYRE or GOOGL in 2026?

Both SYRE and GOOGL have investment merit. SYRE trades at $73.01 while GOOGL trades at $338.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SYRE and GOOGL stock?

Key differences: Market Cap ($5.94B vs N/A), P/E Ratio (N/A vs 31.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 59.7%).

Popular Stock Comparisons